Tehami Dermatology

    Stevens-Johnson syndrome and toxic epidermal necrolysis

    A drug induced, life threatening reaction with mucosal involvement and epidermal detachment. Mortality rises with every day of delay in stopping the culprit drug.

    Updated: 2026-09-12

    Written for clinicians and medical students

    This section is a teaching reference for doctors, residents and medical students. It is not patient guidance and not a substitute for clinical examination, and it must not be used for self treatment.

    What to do now

    • Stop every non-essential drug immediately, above all the likely culprit.
    • Admit. Detachment over 10 percent of body surface area needs burns or intensive care level support.
    • Assess the airway, eyes, mouth and genital mucosa on day one and involve ophthalmology early.
    • Calculate SCORTEN for prognosis, and start fluid, temperature, nutrition and analgesia management.

    Recognition

    • Prodrome of fever and malaise, then painful skin preceding any visible rash.
    • Dusky macules with atypical targets, becoming confluent, with a positive Nikolsky sign.
    • Mucosal erosions at two or more sites: eyes, mouth, genitals.
    • Onset typically 4 to 28 days after starting the responsible drug.

    Common culprit drugs

    • Allopurinol, carbamazepine, lamotrigine, phenytoin, phenobarbital.
    • Sulphonamide antibiotics, nevirapine, oxicam non-steroidal anti-inflammatory drugs.
    • Record every drug started in the preceding 8 weeks with dates, and document the culprit in the notes and to the patient.

    Differential diagnosis

    • Staphylococcal scalded skin syndrome: children, no mucosal erosion, superficial split.
    • Erythema multiforme major: typical targets, often herpes related, limited mucosal disease.
    • Generalised bullous fixed drug eruption, acute graft versus host disease, autoimmune blistering disease.

    Management principles

    • Supportive care is the backbone: warm environment, fluid balance, nutrition, analgesia, non-adherent dressings, no debridement of detached skin as a routine.
    • Eye care from day one prevents the commonest long term disability.
    • Immunomodulation is debated. Ciclosporin and etanercept have the strongest supporting data; systemic corticosteroids and intravenous immunoglobulin remain controversial [1].
    • Document the culprit drug as an allergy, and counsel the patient and first degree relatives, including HLA associations in susceptible groups.

    Sources

    1. [1] Management of Stevens-Johnson syndrome and toxic epidermal necrolysis, PubMed
    2. [2] DermNet, toxic epidermal necrolysis

    By continuing to use this website, you accept our collection of the information necessary to provide our services. See our Privacy Policy.